Literature DB >> 8576260

Characterization of a novel keratinocyte ubiquitin carrier protein.

Z Liu1, A L Haas, L A Diaz, C A Conrad, G J Gíudice.   

Abstract

A novel member of the ubiquitin carrier protein family, designated E2EPF, has been cloned by our laboratory and expressed in a bacterial system in an active form. Ubiquitin carrier proteins, or E2s, catalyze one step in a multistep process that leads to the covalent conjugation of ubiquitin to substrate proteins. In this paper, we show that recombinant E2EPF catalyzes auto/multiubiquitination, the conjugation of multiple ubiquitin molecules to itself. Multiubiquitination has been shown previously to be required for targeting of a substrate protein for rapid degradation. Using a rabbit reticulocyte lysate system, E2EPF was shown to support the degradation of a model substrate in an ATP- and ubiquitin-dependent fashion. In contrast to a previous study which showed that selective protein degradation in one system is dependent upon multiubiquitination via the lysine 48 residue of ubiquitin, multiubiquitination, and proteolytic targeting by E2EPF was shown here to be independent of the lysine 48 multiubiquitin linkage. This functional characterization of E2EPF revealed a combination of features that distinguishes this enzyme from all previously characterized members of the ubiquitin carrier protein family. These results also suggest several possible autoregulatory models for E2EPF involving auto- and multiubiquitination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576260     DOI: 10.1074/jbc.271.5.2817

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Isolation of ubiquitin-E2 (ubiquitin-conjugating enzyme) complexes from erythroleukaemia cells using immunoaffinity techniques.

Authors:  K Takada; T Hirakawa; H Yokosawa; Y Okawa; H Taguchi; K Ohkawa
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

Review 2.  Getting into position: the catalytic mechanisms of protein ubiquitylation.

Authors:  Lori A Passmore; David Barford
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

3.  E1-E2 interactions in ubiquitin and Nedd8 ligation pathways.

Authors:  Zeynep Tokgöz; Thomas J Siepmann; Frederick Streich; Brajesh Kumar; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

4.  UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.

Authors:  L Hu; X Li; Q Liu; J Xu; H Ge; Z Wang; H Wang; Z Wang; C Shi; X Xu; J Huang; Z Lin; R O Pieper; C Weng
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

5.  A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective.

Authors:  Haili Bao; Yi Luo; Guoshan Ding; Zhiren Fu
Journal:  J Oncol       Date:  2022-05-07       Impact factor: 4.501

6.  UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex.

Authors:  Tao Wu; Yifat Merbl; Ying Huo; Jennifer L Gallop; Amit Tzur; Marc W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-06       Impact factor: 11.205

7.  E2-EPF UCP regulates stability and functions of missense mutant pVHL via ubiquitin mediated proteolysis.

Authors:  Kyeong-Su Park; Ju Hee Kim; Hee Won Shin; Kyung-Sook Chung; Dong-Soo Im; Jung Hwa Lim; Cho-Rok Jung
Journal:  BMC Cancer       Date:  2015-10-26       Impact factor: 4.430

8.  E2-EPF UCP Possesses E3 Ubiquitin Ligase Activity via Its Cysteine 118 Residue.

Authors:  Jung Hwa Lim; Hee Won Shin; Kyung-Sook Chung; Nam-Soon Kim; Ju Hee Kim; Hong-Ryul Jung; Dong-Soo Im; Cho-Rok Jung
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.